Clinical Trial Update: Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial of PM00104 (Zalypsis) in advanced/metastatic endometrial or cervical cancer previously treated with one line of chemotherapy was terminated; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer

Drugs mentioned

• PM00104 (Zalypsis) (PM00104)

Snippet

Sponsor: PharmaMar | Conditions: Uterine Cervical Cancer, Endometrial Cancer | Phase 2 | Status: TERMINATED | Results posted: 2021-10-28